Remdesivir in COVID-19: Indication of considerable added benefit for some patients
Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and
Read moreSince July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and
Read moreAfter beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a
Read moreIndia on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with
Read moreResearchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral
Read moreWith over 108 million reported infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, and nearly 2.4 million deaths,
Read moreScientists have developed a method to quickly identify and label mutated versions of the novel coronavirus that causes Covid-19 using
Read moreThe sleep pattern of people was significantly affected in the lockdown with many taking over an hour to fall asleep
Read moreInflammageing – an age-associated phenomenon of increased general inflammation – may be related to the increased severity and mortality of
Read moreCovid-19 pandemic in the country could see a declining trend by mid of September this year, according to the findings
Read more